A detailed history of Resona Asset Management Co.,Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Resona Asset Management Co.,Ltd. holds 431,022 shares of GILD stock, worth $48 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
431,022
Holding current value
$48 Million
% of portfolio
0.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$83.95 - $97.9 $36.2 Million - $42.2 Million
431,022 New
431,022 $39.8 Million
Q3 2024

Feb 20, 2025

SELL
$66.59 - $83.99 $594,781 - $750,198
-8,932 Reduced 1.92%
457,287 $38.3 Million
Q2 2024

Feb 20, 2025

SELL
$63.15 - $72.88 $4.21 Million - $4.85 Million
-66,588 Reduced 12.5%
466,219 $32 Million
Q1 2024

Feb 20, 2025

BUY
$71.58 - $87.29 $7.29 Million - $8.88 Million
101,785 Added 23.61%
532,807 $39 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $140B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Resona Asset Management Co.,Ltd. Portfolio

Follow Resona Asset Management Co.,Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resona Asset Management Co.,Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Resona Asset Management Co.,Ltd. with notifications on news.